Skip to main content

Table 3 Laboratory criteria of the studied VA-ECMO-treated patients

From: Acute vascular complications of femoral veno-arterial ECMO: a single-centre retrospective study

Studied criteria

All patients

Limb ischemia group

No limb ischemia group

P value

Haemoglobin (g/L)

111 (88–166)

105 (88–153)

111 (88–166)

0.9

Platelet count (109/L)

181 (38–447)

160 (112–329)

215 (38–447)

0.32

INR

1.6 (1.1–3.6)

1.9 (1.4–3.2)

1.4 (1.1–3.6)

0.004

aPTT (seconds)

42.2 (31.3–150)

48.2 (33.9–150)

41.3 (31.3–74.3)

0.06

PTT ratio

1.2 (0.9–4.4)

1.4 (1–4.4)

1.2 (0.9–2.2)

0.13

Fibrinogen (g/L)

3.16 (0.76–6.87)

2.38 (0.76–6.87)

3.39 (1.37–6.06)

0.28

Antithrombin III

58 (27–88)

69 (27–88)

55.5 (42–73)

0.002

Serum creatinine (μmol/L)

91 (9.5–320)

115 (48–298)

81 (9.5–320)

0.01

Serum albumin (g/L)

32.2 (18.3–44.1)

37.4 (22.2–44.1)

31.1 (18.3–44.1)

0.04

Serum bilirubin (μmol/L)

28.6 (5.8–389)

58.7 (5.8–79.7)

53.5 (7.5–389)

0.71

PH

7.17 (6.9 –7.34)

7.12 (6.9 – 7.34)

7.20 (6.9 – 7.34)

0.69

Base excess

− 9.3 (− 18.6 to – 4.8)

− 11.2 (− 18.6 to − 5.3)

− 8.25 (− 16.4 to – 4.8)

0.25

Blood lactate (mmol/L)

4.8 (2.4–12.4)

4.8 (3.6–12.4)

5.2 (2.4–10.7)

0.91

Peak blood lactate

13.2 (6.7–20)

13.2 (7.4–20)

11.2 (6.7–20)

0.08

Blood lactate at 24 h

3.1 (1.1–20)

3.1 (1.1–14.3)

2.9 (1.1–20)

0.27

  1. Data are presented as median (IQR)